Wells Fargo & Company Global Blood Therapeutics, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $3.61 Million - $7.61 Million	-111,562 Reduced 42.04%	153,804 $10.5 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $528,911 - $886,816	-23,718 Reduced 8.2%	265,366 $8.48 Million
Q1 2022 May 16, 2022	BUY	$25.68 - $35.59 $3.3 Million - $4.57 Million	128,489 Added 80.01%	289,084 $10 Million
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $1.28 Million - $2.08 Million	51,601 Added 47.34%	160,595 $4.7 Million
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $1.07 Million - $1.57 Million	42,165 Added 63.09%	108,994 $2.78 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $549,872 - $735,534	-16,940 Reduced 20.22%	66,829 $2.34 Million
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $3.2 Million - $4.17 Million	-82,065 Reduced 49.49%	83,769 $3.41 Million
Q4 2020 Feb 09, 2021	BUY	$37.65 - $63.77 $1.05 Million - $1.78 Million	27,841 Added 20.18%	165,834 $7.18 Million
Q3 2020 Nov 05, 2020	BUY	$52.76 - $74.49 $272,294 - $384,442	5,161 Added 3.89%	137,993 $7.61 Million
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $1.2 Million - $2.02 Million	24,684 Added 22.82%	132,832 $8.39 Million
Q1 2020 May 14, 2020	BUY	$41.72 - $87.2 $4.51 Million - $9.43 Million	108,148 New	108,148 $5.53 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.